Related Experiment Videos
[Molecular typing of staphylococcus aureus with randomly amplified polymorphic DNA]
1Department of Clinical Microbiology and Immunology, Hunan Medical University, Changsha 410078.
Hunan Yi Ke Da Xue Xue Bao = Hunan Yike Daxue Xuebao = Bulletin of Hunan Medical University
|April 10, 2002
Summary
Randomly amplified polymorphic DNA (RAPD) molecular typing identified distinct genotypes in Staphylococcus aureus clinical isolates. Primer Ap7 proved most effective for differentiating these bacterial strains.
Area of Science:
- Microbiology
- Molecular Biology
- Genetics
Context:
- Staphylococcus aureus is a significant human pathogen.
- Accurate molecular typing is crucial for infection control and epidemiology.
- Existing typing methods may have limitations in speed or resolution.
Purpose:
- To evaluate the efficacy of Randomly Amplified Polymorphic DNA (RAPD) for molecular typing of clinical Staphylococcus aureus isolates.
- To compare the performance of different RAPD primers (ERIC-2, Ap1, Ap7) in differentiating strains.
- To assess the practicality and value of RAPD as a diagnostic tool.
Summary:
- Twenty-six clinical isolates of Staphylococcus aureus were analyzed using Randomly Amplified Polymorphic DNA (RAPD) analysis with three primers: ERIC-2, Ap1, and Ap7.
- The primers identified 9, 6, and 10 distinct genotypes, respectively.
- Primer Ap7 demonstrated superior performance in discriminating between the Staphylococcus aureus strains, highlighting its effectiveness.
Impact:
- Randomly Amplified Polymorphic DNA (RAPD) offers a simple, rapid, and practical method for the molecular typing of Staphylococcus aureus.
- This technique can aid in tracking the transmission and understanding the genetic diversity of Staphylococcus aureus in clinical settings.
- The findings support the utility of RAPD in routine microbiological diagnostics and epidemiological surveillance.